Leucine Rich Bio Pvt Ltd., Bengaluru, India based, South Asia’s first microbiome focused and genomics driven company and NextGen Life Sciences Pvt. Ltd., Delhi, another India based company which provides “one stop solution” for unmatched combination of innovative technologies have entered into collaboration where in Leucine Rich Bio’s flagship gut microbiome test Bug Speaks® will be marketed through NextGen Life sciences network in India. Leucine Rich Bio developed Bug Speaks® has already been launched in India in select metros and is being currently used by gastroenterologists for their patients and people who want to improve their health by analysing their gut microbiota. Bug Speaks® utilizes patent pending algorithm and matrix including in-house curated and developed databases to generate the report which includes nutritional and probiotic recommendation to restore the gut health apart from providing information on gut microbiota and related disease susceptibilities. NextGen Life Sciences is new generation company serving Science. The company has very good network and is active in wellness domain as well and is also a distributor of many marquee original equipment and reagent manufacturers from across the world. Speaking on this tie up, Dr Debojyoti Dhar, Director, Leucine Rich Bio says “this collaboration will help Bug Speaks® to be experienced by more people in India and hopefully will help provide a new paradigm in healthcare and wellness. We also look forward to opportunities to market Bug Speaks® in other South Asian countries in near future”. Dr Nagma Abbasi, Founder & CEO of NextGen Life sciences also reverberates the same opinion “this collaboration will help us to serve towards improvement of human health and wellness in India which makes me very excited about the promising future. We are proud and highly elated to be associated with Leucine Rice Bio to Market this innovative Diagnostic tool Bug Speaks® and be part of this great initiative of improving human health”.
About Leucine Rich Bio
Leucine Rich Bio Pvt Ltd. is South Asia’s first microbiome company. The company is headquartered in Bengaluru, the Silicon Valley of India. Since its inception in 2014 the company has pioneered the development and standardization of state-of-the-art analytics tools to analyse and interpret complex genomics data. The company is also “Frost & Sullivan” award recipient (2016) for enabling technology in the cloud enabled genomics industry, Asia Pacific region. The company has launched Bug Speaks®- South Asia’s first gut microbiome test. In house developed and patent pending matrix driven interpretation engine along with in house curated databases drive the Bug Speaks®. Bug Speaks® is also part of India’s first gut microbiome based clinical trial. The key areas the company works are in preventive healthcare and precision medicine
About NextGen Life Sciences
An ISO 9001:2015 certified NextGen Life Sciences Pvt. Ltd. understands the scientific needs of the customers and brings in the table perfect solutions as the most innovative solution provider. The company bridges the gap in understanding the needs and pains of Indian Researchers of Life Science Industry and helping Scientists and Biotech Leaders to get an insight on the recent innovation and technologies assuring a sound knowledge of the subject matter of the products. NextGen Life Sciences Pvt. Ltd. since its inception in 2014 is serving Science and always strived to serve its major objective of being a leader in providing integrated, tailored solutions for life Science Researchers and Scientists. Captivated to be a single source of facility to cater the research needs of scientists in the field of Molecular biology, Cell Biology, Immunology, Healthcare, Drug Development and more, the company’s ultimate focus is driven to be One stop Solution for serving Life Science and Health care Industry. NextGen Life Sciences Featured among "Top 20 Best Life Science Start-Ups 2018" by Silicon India Magazine and also Featured as “Startup of the Year 2018” by The CEO Magazine.